2-phenyl-1,2-benzisothiazol-3-(2h)-one has been researched along with Liver Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Frick, DN; Hanson, AM; Isailovic, D; Kolli, R; Marvin, RK; Mukherjee, S; Ndjomou, J; Schoenen, FJ; Schroeder, CE; Simpson, DS; Sweeney, NL; Weiner, WS | 1 |
1 other study(ies) available for 2-phenyl-1,2-benzisothiazol-3-(2h)-one and Liver Neoplasms
Article | Year |
---|---|
Ebselen inhibits hepatitis C virus NS3 helicase binding to nucleic acid and prevents viral replication.
Topics: Antioxidants; Antiviral Agents; Azoles; Carcinoma, Hepatocellular; Cell Proliferation; Electrophoretic Mobility Shift Assay; Hepacivirus; Hepatitis C; Humans; Hydrolysis; Isoindoles; Kinetics; Liver Neoplasms; Models, Molecular; Nucleic Acids; Organoselenium Compounds; Protein Structure, Tertiary; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Tumor Cells, Cultured; Viral Nonstructural Proteins; Virus Replication | 2014 |